A FACTOR INCREASING EFFICIENCY OF A DNA VACCINE AGAINST A VIRUS, A PLASMID DNA FORMULATION, A DNA VACCINE, A METHOD OF OBTAINING A MODIFIED EXPRESSION VECTOR AND USE OF A NUCLEOTIDE SEQUENCE RECOGNISED BY THE NF KAPPA B FACTOR - Patent 3268033

(19)

(11)

EP 3 268 033 A1

(12)

(43)	Date of publication:
	17.01.2018 Bulletin 2018/03

(21)	Application number: 15745258.2

(22)	Date of filing: 09.07.2015

(51)

International Patent Classification (IPC):

A61K 39/12^(2006.01)

A61K 39/00^(2006.01)

(86)	International application number:
	PCT/PL2015/000112

(87)	International publication number:
	WO 2016/144194 (15.09.2016 Gazette 2016/37)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA

(30)

Priority:

11.03.2015 PL 41154315

(71)	Applicant: Instytut Biochemii I Biofizyki Pan
	02-106 Warszawa (PL)

(72)	Inventors:
	SIRKO, Agnieszka 01-227 Warszawa (PL) GÓRA-SOCHACKA, Anna 02-495 Warszawa (PL) ZAGÓRSKI-OSTOJA, Wlodzimierz 02-665 Warszawa (PL) STACHYRA, Anna 04-998 Warszawa (PL) REDKIEWICZ, Patrycja 05-240 Tluszcz (PL) MIDOUX, Patrick 45550 Saint Denis de l'Hotel (FR) PICHON, Chantal 45550 Saint Denis de l'Hôtel (FR)

(74)	Representative: Twardowska, Aleksandra
	Kulikowska & Kulikowski Roma Office Center ul.Nowogrodzka 47A 00-695 Warszawa 00-695 Warszawa (PL)

(54)	A FACTOR INCREASING EFFICIENCY OF A DNA VACCINE AGAINST A VIRUS, A PLASMID DNA FORMULATION, A DNA VACCINE, A METHOD OF OBTAINING A MODIFIED EXPRESSION VECTOR AND USE OF A NUCLEOTIDE SEQUENCE RECOGNISED BY THE NF KAPPA B FACTOR